Monday, October 15, 2018
Video: Page (1) of 1 - 05/23/14 Email this story to a friend. email article Print this page (Article printing at page facebook
New Options For Trading Astrazeneca

By DMO Affiliate
Astrazeneca is off its 52 week high after rebuffing offers from Pfizer this month. In its final proposal announcement, Pfizer announced a possible offer comprising, for each AstraZeneca share, 1.747 shares in the combined entity and 2,476 pence in cash, representing an indicative value of £55.001. Shares of AZN are trading at $72.67 this morning versus a 52 week high of $82.68.
New Options For Trading Astrazeneca

Page: 1


Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines